Panagora Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $360K | Hold |
3,977
| – | – | ﹤0.01% | 985 |
|
|
2026
Q1 | $318K | Hold |
3,977
| – | – | ﹤0.01% | 957 |
|
|
2025
Q4 | $339K | Sell |
3,977
-637
| -14% | -$52.3K | ﹤0.01% | 969 |
|
|
2025
Q3 | $359K | Hold |
4,614
| – | – | ﹤0.01% | 907 |
|
|
2025
Q2 | $361K | Sell |
4,614
-5,224
| -53% | -$390K | ﹤0.01% | 889 |
|
|
2025
Q1 | $713K | Sell |
9,838
-82
| -0.8% | -$5.87K | ﹤0.01% | 733 |
|
|
2024
Q4 | $734K | Buy |
9,920
+682
| +7% | +$47.7K | ﹤0.01% | 729 |
|
|
2024
Q3 | $610K | Sell |
9,238
-3
| -0% | -$218 | ﹤0.01% | 874 |
|
|
2024
Q2 | $854K | Sell |
9,241
-9,112
| -50% | -$807K | ﹤0.01% | 769 |
|
|
2024
Q1 | $1.75M | Hold |
18,353
| – | – | 0.01% | 612 |
|
|
2023
Q4 | $1.4M | Hold |
18,353
| – | – | 0.01% | 691 |
|
|
2023
Q3 | $1.27M | Sell |
18,353
-121
| -0.7% | -$9.72K | 0.01% | 701 |
|
|
2023
Q2 | $1.74M | Sell |
18,474
-8
| -0% | -$695 | 0.01% | 582 |
|
|
2023
Q1 | $1.53M | Sell |
18,482
-45,356
| -71% | -$3.57M | 0.01% | 670 |
|
|
2022
Q4 | $4.76M | Buy |
63,838
+8,129
| +15% | +$627K | 0.03% | 392 |
|
|
2022
Q3 | $4.6M | Sell |
55,709
-105
| -0.2% | -$10.1K | 0.03% | 378 |
|
|
2022
Q2 | $5.31M | Buy |
55,814
+36,795
| +193% | +$3.81M | 0.03% | 367 |
|
|
2022
Q1 | $2.24M | Buy |
19,019
+4,870
| +34% | +$546K | 0.01% | 649 |
|
|
2021
Q4 | $1.83M | Sell |
14,149
-10,842
| -43% | -$1.26M | 0.01% | 675 |
|
|
2021
Q3 | $2.83M | Buy |
24,991
+69
| +0.3% | +$7.88K | 0.02% | 574 |
|
|
2021
Q2 | $2.58M | Sell |
24,922
-508
| -2% | -$47.9K | 0.01% | 638 |
|
|
2021
Q1 | $2.13M | Sell |
25,430
-211
| -0.8% | -$17.8K | 0.01% | 713 |
|
|
2020
Q4 | $2.34M | Sell |
25,641
-611
| -2% | -$50.7K | 0.01% | 646 |
|
|
2020
Q3 | $2.1M | Buy |
26,252
+60
| +0.2% | +$4.68K | 0.01% | 621 |
|
|
2020
Q2 | $1.81M | Sell |
26,192
-398,422
| -94% | -$28.3M | 0.01% | 710 |
|
|
2020
Q1 | $26.7M | Buy |
424,614
+354,081
| +502% | +$25.5M | 0.19% | 118 |
|
|
2019
Q4 | $5.49M | Buy |
70,533
+39,777
| +129% | +$3.11M | 0.02% | 464 |
|
|
2019
Q3 | $2.25M | Buy |
30,756
+255
| +0.8% | +$17.9K | 0.01% | 698 |
|
|
2019
Q2 | $1.88M | Buy |
30,501
+945
| +3% | +$57.1K | 0.01% | 859 |
|
|
2019
Q1 | $1.89M | Sell |
29,556
-2,703
| -8% | -$154K | 0.01% | 861 |
|
|
2018
Q4 | $1.65M | Sell |
32,259
-1,875
| -5% | -$94.9K | 0.01% | 859 |
|
|
2018
Q3 | $1.98M | Sell |
34,134
-477,696
| -93% | -$23.4M | 0.01% | 844 |
|
|
2018
Q2 | $24.8M | Sell |
511,830
-89,283
| -15% | -$4.17M | 0.1% | 203 |
|
|
2018
Q1 | $28M | Buy |
601,113
+349,656
| +139% | +$15.2M | 0.11% | 182 |
|
|
2017
Q4 | $9.45M | Buy |
251,457
+197,853
| +369% | +$7.26M | 0.04% | 402 |
|
|
2017
Q3 | $1.95M | Sell |
53,604
-37,338
| -41% | -$1.42M | 0.01% | 871 |
|
|
2017
Q2 | $3.58M | Sell |
90,942
-43,347
| -32% | -$1.58M | 0.01% | 670 |
|
|
2017
Q1 | $4.21M | Sell |
134,289
-1,013,094
| -88% | -$31.7M | 0.02% | 632 |
|
|
2016
Q4 | $35.8M | Buy |
1,147,383
+5,181
| +0.5% | +$168K | 0.16% | 138 |
|
|
2016
Q3 | $45.9M | Sell |
1,142,202
-118,101
| -9% | -$4.45M | 0.22% | 106 |
|
|
2016
Q2 | $41.9M | Sell |
1,260,303
-86,460
| -6% | -$2.96M | 0.21% | 99 |
|
|
2016
Q1 | $39.6M | Sell |
1,346,763
-309,045
| -19% | -$8.53M | 0.2% | 111 |
|
|
2015
Q4 | $43.6M | Sell |
1,655,808
-15,972
| -1% | -$415K | 0.21% | 113 |
|
|
2015
Q3 | $39.6M | Sell |
1,671,780
-269,250
| -14% | -$6.5M | 0.21% | 115 |
|
|
2015
Q2 | $46.1M | Buy |
1,941,030
+55,536
| +3% | +$1.25M | 0.23% | 103 |
|
|
2015
Q1 | $44.8M | Buy |
1,885,494
+1,099,146
| +140% | +$24.7M | 0.23% | 114 |
|
|
2014
Q4 | $16.7M | Buy |
786,348
+396,870
| +102% | +$7.97M | 0.09% | 236 |
|
|
2014
Q3 | $6.63M | Buy |
389,478
+319,506
| +457% | +$5.04M | 0.03% | 419 |
|
|
2014
Q2 | $1M | Sell |
69,972
-29,244
| -29% | -$396K | ﹤0.01% | 1118 |
|
|
2014
Q1 | $1.23M | Buy |
99,216
+14,328
| +17% | +$165K | 0.01% | 1097 |
|
|
2013
Q4 | $930K | Buy |
84,888
+12,936
| +18% | +$146K | ﹤0.01% | 1197 |
|
|
2013
Q3 | $835K | Sell |
71,952
-2,466
| -3% | -$28.9K | ﹤0.01% | 1178 |
|
|
2013
Q2 | $833K | Buy |
+74,418
| New | +$881K | ﹤0.01% | 1124 |
|
Other funds holding EW
Panagora Asset Management's EW Position: Q2 2026 in Review
Panagora Asset Management held its Edwards Lifesciences (EW) position steady in Q2 2026 at 3,977 shares worth $360K. The position accounts for ﹤0.01% of the portfolio, ranked #985.
Panagora Asset Management first reported a position in EW in Q2 2013 and has held it in 53 quarters since. The position peaked at $46.1M in Q2 2015. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Panagora Asset Management held 3,977 shares of Edwards Lifesciences worth $360K as of Q2 2026.
- Panagora Asset Management left its Edwards Lifesciences share count unchanged in Q2 2026.
- Edwards Lifesciences made up ﹤0.01% of Panagora Asset Management's portfolio in Q2 2026, its #985 holding.
- Panagora Asset Management first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 53 quarters since.
- Panagora Asset Management's Edwards Lifesciences position peaked at $46.1M in Q2 2015.
- 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.